Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Am Heart J. 2014 Apr 2;168(1):37–44.e5. doi: 10.1016/j.ahj.2014.02.012

Table 3.

Patient Status by all Treatment Arms

EDTA Chelation & High-Dose Vitamins (N= 421) EDTA Chelation & Placebo Vitamins (N= 418) Placebo Infusions & High-Dose Vitamins (N= 432) Placebo Infusions & Placebo Vitamins (N= 437) P-value
Patient Status
    Number of infusions 40 (32, 40) 40 (31, 40) 40 (26, 40) 40 (30, 40) 0.401
    Discontinued infusions 114 (27%) 119 (28%) 146 (34%) 135 (31%) 0.152
    Completed 30 infusions 324 (77%) 323 (77%) 319 (74%) 329 (75%) 0.622
    Completed 40 infusions 283 (67%) 282 (67%) 267 (62%) 285 (65%) 0.275
    Discontinued vitamins 185 (44%) 185 (44%) 209 (48%) 205 (47%) 0.503
    Continued vitamins for at least 1 year 328 (78%) 321 (77%) 317 (73%) 325 (74%) 0.384
    Continued vitamins for at least 3 years 210 (50%) 216 (52%) 190 (44%) 210 (48%) 0.135
    Consent withdrawal 50 (12%) 65 (16%) 91 (21%) 83 (19%) 0.002